S-1: Waystar Holding Corp. Selling Stockholders Offer 18 Million Shares in S-1 Filing
S-1 Filing
Selling stockholders of Waystar Holding Corp. are offering 18 million shares of common stock in a newly filed S-1 registration statement.
Summary
- Waystar Holding Corp. has filed an S-1 registration statement for a secondary offering of 18 million shares of common stock by selling stockholders.
- The company will not receive any proceeds from the sale of these shares.
- The offering includes an option for underwriters to purchase up to 2.7 million additional shares from the selling stockholders.
- The filing details the company's business, financial condition, risk factors, and future outlook.
- Waystar is an emerging growth company and has elected to comply with certain reduced public company reporting requirements.
- The company's common stock is listed on the Nasdaq Global Select Market under the symbol WAY.
- As of February 14, 2025, the last reported sale price of Waystar's common stock on Nasdaq was $45.35 per share.
Sentiment
Score: 6
Explanation: The document is neutral in tone, as it is a regulatory filing. The information presented is factual and does not express a strong positive or negative sentiment.
Positives
- The company's common stock is listed on the Nasdaq Global Select Market under the symbol WAY.
- Waystar is classified as an emerging growth company, allowing for reduced reporting requirements.
Negatives
- The company will not receive any proceeds from the sale of shares by the selling stockholders.
Risks
- Investing in the company's common stock involves risks, as detailed in the Risk Factors section of the prospectus.
- The Institutional Investors will continue to hold a significant percentage of our outstanding common stock after this offering and their interests may be different than the interests of other holders of our securities.
- The market price of our common stock has been volatile and may continue to fluctuate substantially, which could result in substantial losses for purchasers of our common stock.
Future Outlook
The company plans to capitalize on its market opportunity by expanding relationships with existing clients, growing its client base, deepening relationships with strategic channel partners, innovating and developing adjacent solutions, and selectively pursuing strategic acquisitions.
Management Comments
- Our mission is to simplify healthcare payments through our modern cloud-based software, enabling our healthcare clients to prioritize patient care and optimize their financial performance.
Industry Context
The healthcare payment ecosystem is highly complex, and Waystar's platform aims to address the challenges faced by healthcare providers by optimizing healthcare payments across all stages of the patient journey.
Comparison to Industry Standards
- The company believes its platform significantly outperforms those of its competitors, who lack either modern functionality or the ability to address the full end-to-end payments workflow.
- Waystar had an 83% win rate against its competitors for fiscal years 2022 through 2024 in situations where the client ultimately elected to switch vendors or purchase a new solution.
Stakeholder Impact
- The offering provides liquidity for existing shareholders.
- The offering could potentially impact the share price.
Next Steps
- The offering will proceed as soon as practicable after the Registration Statement is declared effective.
Key Dates
| Date | Description |
|---|---|
| August 13, 2019 | Waystar Holding Corp. originally incorporated in Delaware. |
| October 22, 2019 | First Lien Credit Agreement dated. |
| August 13, 2021 | Receivables Financing Agreement dated. |
| June 10, 2024 | Stockholders Agreement dated. |
| June 2024 | Waystar initial public offering at a price of $21.50 per share. |
| February 14, 2025 | Last reported sale price of Waystar's common stock on Nasdaq was $45.35 per share. |
| February 18, 2025 | Date of the S-1 filing. |
Keywords
secondary offering, common stock, S-1 filing, Waystar Holding Corp., selling stockholders, underwriters, emerging growth company, Nasdaq, WAY, healthcare payments
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.